EV/EBITDA
-21.45
-0.13-0.61%
18 min ago
Summary:
Esperion Therapeutics EV/EBITDA is currently -21.45, with a fall of -0.13 (-0.61%) during the most recent trading day. Over the past year, it has dropped by -19.48 (-988.83%). ESPR EV/EBITDA is now -1717.80% below its all-time high of -1.18.ESPR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -0.6% |
| 1 m1 month | -16.6% |
| 3 m3 months | -106.0% |
| 6 m6 months | -32.1% |
| ytdytd | -495.8% |
| 1 y1 year | -988.8% |
| 5 y5 years | -63.6% |
ESPR EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -18.04 | -18.9% | -21.86 | +1.9% |
| 3 m | 3 months | -9.78 | -119.3% | -21.86 | +1.9% |
| 6 m | 6 months | -9.78 | -119.3% | -21.86 | +1.9% |
| 1 y | 1 year | -1.93 | -1011.4% | -23.68 | +9.4% |
| 3 y | 3 years | -1.18 | -1717.8% | -23.68 | +9.4% |
| 5 y | 5 years | -1.18 | -1717.8% | -23.68 | +9.4% |
| alltime | all time | -1.18 | -1717.8% | -61.85 | +65.3% |
Esperion Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -21.45(+495.8%) |
| 2023 | -3.60(+3.7%) |
| 2022 | -3.47(+116.9%) |
| 2021 | -1.60(-65.3%) |
| 2020 | -4.61(-72.3%) |
| 2019 | -16.63(+182.3%) |
| Date | Value |
|---|---|
| 2018 | -5.89(-42.3%) |
| 2017 | -10.20(+207.2%) |
| 2016 | -3.32(-62.0%) |
| 2015 | -8.73(-57.7%) |
| 2014 | -20.66(+235.9%) |
| 2013 | -6.15 |
FAQ
- What is Esperion Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Esperion Therapeutics?
- What is ESPR EV/EBITDA year-to-date change?
- What is Esperion Therapeutics EV/EBITDA year-on-year change?
What is Esperion Therapeutics EV/EBITDA?
The current EV/EBITDA of ESPR is -21.45
What is the all time high EV/EBITDA for Esperion Therapeutics?
Esperion Therapeutics all-time high EV/EBITDA is -1.18
What is ESPR EV/EBITDA year-to-date change?
Esperion Therapeutics EV/EBITDA has changed by -17.85 (-495.83%) since the beginning of the year
What is Esperion Therapeutics EV/EBITDA year-on-year change?
Over the past year, ESPR EV/EBITDA has changed by -19.48 (-988.83%)